Anxiolytic Effects in Mice of a Dual Blocker of Fatty Acid Amide Hydrolase and Transient Receptor Potential Vanilloid Type-1 Channels

被引:158
作者
Micale, Vincenzo [1 ]
Cristino, Luigia [2 ]
Tamburella, Alessandra [1 ]
Petrosino, Stefania
Leggio, Gian Marco [1 ]
Drago, Filippo [1 ]
Di Marzo, Vincenzo
机构
[1] Catania Univ, Sch Med, Dept Expt & Clin Pharmacol, Catania, Italy
[2] CNR, Inst Cybernet, Endocannabinoid Res Grp, Naples, Italy
关键词
endocannabinoid; endovanilloid; FAAH; TRPV1; CB1; anxiety; ANXIETY-LIKE BEHAVIOR; ENDOCANNABINOID SYSTEM; CANNABINOID RECEPTOR-TYPE-1; DOPAMINERGIC-NEURONS; REDUCED ANXIETY; ANANDAMIDE; TRPV1; BRAIN; INHIBITORS; CB1;
D O I
10.1038/npp.2008.98
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The endocannabinoid-inactivating enzyme, fatty acid amide hydrolase (FAAH), and the transient receptor potential vanilloid type-1 (TRPV1) channel are new targets for the development of anxiolytic drugs. We studied the effect on anxiety-like behavior in the elevated plus maze of a dual FAAH/TRPV1 blocker, N-arachidonoyl-serotonin (AA-5-HT). In male C57BL/6J mice, acute intraperitoneal administration of AA-5-HT (0.1-2.5 mg/kg) increased both the time spent and the number of entries in the open arm, while being inactive at the highest dose tested (5 mg/kg). AA-5-HT was more potent than selective blockers of FAAH or TRPV1 (URB597 and SB366791, respectively). In male Swiss mice, AA-5-HT had to be administered chronically to observe an anxiolytic effect at an intermediate dose (2.5 mg/kg), the highest dose (5 mg/kg) being anxiogenic, and 1 mg/kg being ineffective. In both strains, the anxiolytic effects of AA-5-HT were paralleled by elevation of brain endocannabinoid levels and were reversed by per se inactive doses of the cannabinoid receptors of type-1 (CB1) receptor antagonist AM251, or the TRPV1 agonist, olvanil. Immunohistochemical localization of CB1 and TRPV1 receptors was observed in mouse prefrontal cortex, nucleus accumbens, amygdala, and hippocampus. Simultaneous 'indirect' activation of CB1 receptors following FAAH inhibition, and antagonism at TRPV1 receptors might represent a new therapeutic strategy against anxiety.
引用
收藏
页码:593 / 606
页数:14
相关论文
共 59 条
[1]   Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro [J].
Ahluwalia, J ;
Urban, L ;
Bevan, S ;
Nagy, I .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2003, 17 (12) :2611-2618
[2]   Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase [J].
Bisogno, T ;
Melck, D ;
De Petrocellis, L ;
Bobrov, MY ;
Gretskaya, NM ;
Bezuglov, VV ;
Sitachitta, N ;
Gerwick, WH ;
Di Marzo, V .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :515-522
[3]   Development of the first potent and specific inhibitors of endocannabinoid biosynthesis [J].
Bisogno, T ;
Cascio, MG ;
Saha, B ;
Mahadevan, A ;
Urbani, P ;
Minassi, A ;
Appendino, G ;
Saturnino, C ;
Martin, B ;
Razdan, R ;
Di Marzo, V .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2006, 1761 (02) :205-212
[4]   Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders [J].
Bisogno, Tiziana ;
Di Marzo, Vincenzo .
PHARMACOLOGICAL RESEARCH, 2007, 56 (05) :428-442
[5]   A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol [J].
Blankman, Jacqueline L. ;
Simon, Gabriel M. ;
Cravatt, Benjamin F. .
CHEMISTRY & BIOLOGY, 2007, 14 (12) :1347-1356
[6]   Behavioral effects of the β3 adrenoceptor agonist SR58611A:: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? [J].
Consoli, Daniele ;
Leggio, Gian Marco ;
Mazzola, Carmen ;
Micale, Vincenzo ;
Drago, Filippo .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 573 (1-3) :139-147
[7]   Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies [J].
Crawley, JN ;
Belknap, JK ;
Collins, A ;
Crabbe, JC ;
Frankel, W ;
Henderson, N ;
Hitzemann, RJ ;
Maxson, SC ;
Miner, LL ;
Silva, AJ ;
Wehner, JM ;
WynshawBoris, A ;
Paylor, R .
PSYCHOPHARMACOLOGY, 1997, 132 (02) :107-124
[8]   Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain [J].
Cristino, L. ;
De Petrocellis, L. ;
Pryce, G. ;
Baker, D. ;
Guglielmotti, V. ;
Di Marzo, V. .
NEUROSCIENCE, 2006, 139 (04) :1405-1415
[9]   Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels [J].
de Lago, E ;
Petrosino, S ;
Valenti, M ;
Morera, E ;
Ortega-Gutierrez, S ;
Fernandez-Ruiz, J ;
Di Marzo, V .
BIOCHEMICAL PHARMACOLOGY, 2005, 70 (03) :446-452
[10]   Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity [J].
De Petrocellis, L ;
Bisogno, T ;
Davis, JB ;
Pertwee, RG ;
Di Marzo, V .
FEBS LETTERS, 2000, 483 (01) :52-56